Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator

American Heart Journal

Volumn 153, Issue 1, 2007, Pages 120-126

  Rienstra, Michiel ^a   Smit, Marcelle D ^a   Nieuwland, Wybe ^a   Tan, Eng S ^a   Wiesfeld, Ans C P ^a   Anthonio, Rutger L ^a   Van den Berg, Maarten P ^a   Van Veldhuisen, Dirk J ^a   Van Gelder, Isabelle C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; HEALTH CARE ORGANIZATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEAT SHOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; EQUIPMENT FAILURE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845327529     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.09.010     Document Type: Article

References (30)

1. Van Den Berg P.M., Van Gelder I.C., and Van Veldhuisen D.J. Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 4 (2002) 571-575
2. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003) 2920-2925
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
4. Johnstone D., Limacher M., Rousseau M., et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 70 (1992) 894-900
5. Carson P.E., Johnson G.R., Dunkman W.B., et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993) VI102-VI110
6. Crijns H.J., Tjeerdsma G., De Kam P.J., et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21 (2000) 1238-1245
7. Stevenson W.G., Stevenson L.W., Middlekauff H.R., et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 28 (1996) 1458-1463
8. Roy D., Brugada P., and Wellens H.J. Atrial tachycardia facilitating initiation of ventricular tachycardia. Pacing Clin Electrophysiol 6 1 Pt 1 (1983) 47-52
9. Stein K.M., Euler D.E., Mehra R., et al. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?. J Am Coll Cardiol 40 (2002) 335-340
10. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
11. Hylek E.M., and Singer D.E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120 (1994) 897-902
12. Marchlinski F.E., Callans D.J., Gottlieb C.D., et al. Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 6 10 Pt 1 (1995) 832-851
13. Grönefeld G.C., Mauss O., Li Y.G., et al. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 11 (2000) 1208-1214
14. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 (2002) 2145-2161
15. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J 24 (2003) 13-15
16. Wiesfeld A.C., Crijns H.J., Hillege H.L., et al. The clinical significance of coronary anatomy in post-infarct patients with late sustained ventricular tachycardia or ventricular fibrillation. Eur Heart J 16 (1995) 818-824
17. Singh J.P., Hall W.J., McNitt S., et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
18. Zareba W., Steinberg J.S., McNitt S., et al. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3 (2006) 631-637
19. Whang W., Mittleman M.A., Rich D.Q., et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) Study. Circulation 109 (2004) 1386-1391
20. Lerman B.B. Mechanoelectrical feedback: maturation of a concept. J Cardiovasc Electrophysiol 7 (1996) 17-19
21. Stein K.M., Karagounis L.A., Markowitz S.M., et al. Heart rate changes preceding ventricular ectopy in patients with ventricular tachycardia caused by reentry, triggered activity, and automaticity. Am Heart J 136 (1998) 425-434
22. Denker S., Lehmann M., Mahmud R., et al. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 53 (1984) 508-515
23. Ellenbogen K.A., Levine J.H., Berger R.D., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782
24. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
25. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288 (2002) 3115-3123
26. Smit M.D., Van Dessel P.F., Nieuwland W., et al. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. Heart Rhythm (2006) [in press]
27. Swedberg K., Olsson L.G., Charlesworth A., et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26 (2005) 1303-1308
28. Pozzoli M., Cioffi G., Traversi E., et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
29. Grimm W., Flores B.F., and Marchlinski F.E. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 15 11 Pt 1 (1992) 1667-1673
30. Schmitt C., Montero M., and Melichercik J. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 17 3 Pt 1 (1994) 295-302